http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014350629-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a2d0386aa08b9b63d58204eef6a22cd |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3628 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-368 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-368 |
| filingDate | 2014-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7fa98ad3509ccd40cc38d027f47cbbf |
| publicationDate | 2014-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2014350629-A1 |
| titleOfInvention | System and method for stimulating the heart in combination with cardiac rhythm management pharmaceuticals |
| abstract | Sensors are applied to the heart and sensor data is supplied to a rules engine. The rules engine applies rules that reflect a CRM pharmaceutical regime of the patient to the sensor data to determine whether an electrical waveform should be applied to the heart. When electrical stimulation is warranted, the drug “awareness” rules are used by the rules engine to instruct a multi-phase cardiac stimulus generator to generate an electrical waveform that improves the performance of the drugs administered to the patient, allow the patient to be administered a lower dose of a particular drug, and/or reduce or eliminate side effects from the drugs. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10940318-B2 |
| priorityDate | 2013-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.